295 related articles for article (PubMed ID: 26498154)
1. Mast cell tryptase and chymase in the progress of cutaneous vasculitis.
Lipitsä T; Naukkarinen A; Harvima IT
Arch Dermatol Res; 2015 Dec; 307(10):917-24. PubMed ID: 26498154
[TBL] [Abstract][Full Text] [Related]
2. Complement C3 is expressed by mast cells in cutaneous vasculitis and is degraded by chymase.
Lipitsä T; Naukkarinen A; Laitala J; Harvima IT
Arch Dermatol Res; 2016 Oct; 308(8):575-84. PubMed ID: 27465068
[TBL] [Abstract][Full Text] [Related]
3. The increase in tryptase- and chymase-positive mast cells is associated with partial inactivation of chymase and increase in protease inhibitors in basal cell carcinoma.
Diaconu NC; Kaminska R; Naukkarinen A; Harvima RJ; Harvima IT
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):908-15. PubMed ID: 17658999
[TBL] [Abstract][Full Text] [Related]
4. Mast cell tryptase and chymase in chronic leg ulcers: chymase is potentially destructive to epithelium and is controlled by proteinase inhibitors.
Huttunen M; Harvima IT
Br J Dermatol; 2005 Jun; 152(6):1149-60. PubMed ID: 15948975
[TBL] [Abstract][Full Text] [Related]
5. Alterations in mast cell proteinases and protease inhibitors in the progress of cutaneous herpes zoster infection.
Kaminska R; Harvima IT; Naukkarinen A; Nilsson G; Horsmanheimo M
J Pathol; 1996 Dec; 180(4):434-40. PubMed ID: 9014866
[TBL] [Abstract][Full Text] [Related]
6. Mast cell tryptase and chymase in developing and mature psoriatic lesions.
Harvima IT; Naukkarinen A; Paukkonen K; Harvima RJ; Aalto ML; Schwartz LB; Horsmanheimo M
Arch Dermatol Res; 1993; 285(4):184-92. PubMed ID: 8342961
[TBL] [Abstract][Full Text] [Related]
7. Release of soluble tryptase but only minor amounts of chymase activity from cutaneous mast cells.
Kivinen PK; Kaminska R; Naukkarinen A; Harvima RJ; Horsmanheimo M; Harvima IT
Exp Dermatol; 2001 Aug; 10(4):246-55. PubMed ID: 11493313
[TBL] [Abstract][Full Text] [Related]
8. Mast cell chymase degrades fibrinogen and fibrin.
Lipitsä T; Siiskonen H; Naukkarinen A; Harvima IT
Br J Dermatol; 2019 Aug; 181(2):296-303. PubMed ID: 30561017
[TBL] [Abstract][Full Text] [Related]
9. Mast cells in developing subepidermal bullous diseases: emphasis on tryptase, chymase and protease inhibitors.
Kaminska R; Naukkarinen A; Glinski W; Horsmanheimo M; Harvima IT
Acta Derm Venereol; 1999 Sep; 79(5):351-5. PubMed ID: 10494709
[TBL] [Abstract][Full Text] [Related]
10. Increased numbers of tryptase-positive mast cells in the healthy and sun-protected skin of tobacco smokers.
Kaukinen A; Fitzgibbon A; Oikarinen A; Hinkkanen L; Viinikanoja M; Harvima IT
Dermatology; 2014; 229(4):353-8. PubMed ID: 25376107
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-4-positive mast cells are highly associated with the extent of immediate allergic wheal reaction in the skin.
Saarinen JV; Harvima RJ; Naukkarinen A; Horsmanheimo M; Harvima IT
Allergy; 2001 Jan; 56(1):58-64. PubMed ID: 11167353
[TBL] [Abstract][Full Text] [Related]
12. Low numbers of tryptase+ and chymase+ mast cells associated with reduced survival and advanced tumor stage in melanoma.
Siiskonen H; Poukka M; Bykachev A; Tyynelä-Korhonen K; Sironen R; Pasonen-Seppänen S; Harvima IT
Melanoma Res; 2015 Dec; 25(6):479-85. PubMed ID: 26317168
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of mast cell chymase and tryptase and of c-Kit in human cutaneous scar tissue.
Hermes B; Feldmann-Böddeker I; Welker P; Algermissen B; Steckelings MU; Grabbe J; Henz BM
J Invest Dermatol; 2000 Jan; 114(1):51-5. PubMed ID: 10620115
[TBL] [Abstract][Full Text] [Related]
14. Decreased chymase activity is associated with increased levels of protease inhibitors in mast cells of psoriatic lesions.
Harvima IT; Haapanen L; Ackermann L; Naukkarinen A; Harvima RJ; Horsmanheimo M
Acta Derm Venereol; 1999 Mar; 79(2):98-104. PubMed ID: 10228625
[TBL] [Abstract][Full Text] [Related]
15. [Correlations between chymase activity, levels of tryptase, and eotaxin in the sputum of patients with chronic obstructive pulmonary disease and their clinical implications].
Zhang XJ; He SH; Xie H; Wei JF; Liu CT
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Oct; 27(10):649-53. PubMed ID: 16200864
[TBL] [Abstract][Full Text] [Related]
16. Role of mast cell chymase and tryptase in the progression of atherosclerosis: study in 44 autopsied cases.
Ramalho LS; Oliveira LF; Cavellani CL; Ferraz ML; de Oliveira FA; Miranda Corrêa RR; de Paula Antunes Teixeira V; De Lima Pereira SA
Ann Diagn Pathol; 2013 Feb; 17(1):28-31. PubMed ID: 22658852
[TBL] [Abstract][Full Text] [Related]
17. The release of histamine is associated with the inactivation of mast cell chymase during immediate allergic wheal reaction in the skin.
Saarinen JV; Harvima RJ; Naukkarinen A; Horsmanheimo M; Harvima IT
Clin Exp Allergy; 2001 Apr; 31(4):593-601. PubMed ID: 11359428
[TBL] [Abstract][Full Text] [Related]
18. The production of collagen and the activity of mast-cell chymase increase in human skin after irradiation therapy.
Riekki R; Harvima IT; Jukkola A; Risteli J; Oikarinen A
Exp Dermatol; 2004 Jun; 13(6):364-71. PubMed ID: 15186323
[TBL] [Abstract][Full Text] [Related]
19. Mast cells in melanocytic skin lesions. An immunohistochemical and quantitative study.
Dyduch G; Okoń K; Pescarini E
Pol J Pathol; 2011 Sep; 62(3):139-44. PubMed ID: 22102069
[TBL] [Abstract][Full Text] [Related]
20. Demonstration of tryptase in bovine cutaneous and tumor mast cells.
Welle MM; Proske SM; Harvima IT; Schechter NM
J Histochem Cytochem; 1995 Nov; 43(11):1139-44. PubMed ID: 7560896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
